View Document Preview and Link Document Date: 2014-06-17 00:16:36 Open Document File Size: 652,30 KB Share Result on Facebook
City Initial Weight / / Company Lennox / Human Overdose Experience / GlaxoSmithKline / / Event FDA Phase / Product Issues / Product Recall / / Facility Laboratory Tests ADVERSE REACTIONS / / IndustryTerm treatment of Bipolar I Disorder / treatment of bipolar disorder / therapy for epilepsy / / MedicalCondition partial seizures / bipolar and other mood disorders / headache / seizures / primary generalized tonic-clonic seizures / nausea / thrombocytopenia / rhinitis / toxic epidermal necrolysis / Stevens-Johnson syndrome / tremor / General Dosing Considerations Rash / StevensJohnson syndrome / fatigue / lymphadenopathy / hypersensitivity / hepatitis / xerostomia / associated hypersensitivity syndrome / back pain / Bipolar Disorder LAMICTAL / serious rash / ataxia / Aseptic meningitis / abdominal pain / insomnia / accidental injury / Multiorgan hypersensitivity / I Disorder / Withdrawal Seizures / nonserious rash / chronic treatment / Carcinogenesis / neutropenia / mania / Patients With Epilepsy / fever / allergy / seizure / vomiting / Life-threatening serious rash / hepatic failure / epilepsy / infection / dizziness / depression / diplopia / rash / pharyngitis / Eosinophilia / Status Epilepticus / bipolar disorder / pancytopenia / / MedicalTreatment Medication errors / oral contraceptives / Hormone Replacement Therapy / adjunctive therapy / / Organization Administration of LAMICTAL Chewable Dispersible Tablets / Administration of LAMICTAL ODT Orally Disintegrating Tablets DOSAGE FORMS AND STRENGTHS / DOSAGE AND ADMINISTRATION / FDA / / / Position physician / General / / Product Chewable Dispersible Tablets / Potential Medication Errors 5.8 Concomitant Use / ODT Orally Disintegrating Tablets / primidone / divalproex sodium / carbamazepine / rifampin / phenytoin / Potential Medication / lamotrigine / Orally Disintegrating Tablets / valproic acid / LAMICTAL / experience / contraceptives / / Technology Pharmacokinetics / Pharmacodynamics / / URL www.fda.gov/medwatch / / SocialTag 
------------------------------- CONTRAINDICATIONS -----------------------Hypersensitivity to the drug or its ingredients. (Boxed Warning, 4) ----------------------- WARNINGS AND PRECAUTIONS ---------------• Life-threat